Roivant’s autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news Adobe Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. We have some news out of a meeting of the European Society of Cardiology, Roivant won a key autoimmune drug approval, and former Stanford president Marc Tessier-Lavigne is pushing back against revived allegations of research fraud. RIP to Yayoi Kusama. Wearing manic polka dots today in tribute. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Meghana Keshavan covers biotech and contributes to The Readout newsletter.
STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.